Jonathan Schechter - 05 Apr 2022 Form 4/A - Amendment Insider Report for Synaptogenix, Inc. (SNPX)

Role
Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Issuer symbol
SNPX
Transactions as of
05 Apr 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
23 Jun 2022, 18:00:35 UTC
Date Of Original Report
06 Apr 2022
Previous filing
15 Jul 2021
Next filing
23 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPX Stock Option (Right to Buy) Other 0 0 05 Apr 2022 Common Stock, par value $0.0001 per share Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio.